After achieving remission, patients with APL require regular follow-up and monitoring to detect any signs of relapse. This typically involves periodic blood tests, bone marrow examinations, and molecular testing for the PML-RARA fusion gene. Maintenance therapy may also be prescribed to reduce the risk of relapse, and supportive care is important to manage any treatment-related side effects.
